An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

NCT00113607 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

672

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Trabectedin
DRUG: DOXIL
DRUG: Dexamethasone

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]